BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1433799)

  • 1. Appearance of a methotrexate binding plasma protein during high dose methotrexate therapy.
    Iqbal MP; Malik I; Mehboobali N
    J Pak Med Assoc; 1992 Aug; 42(8):193-6. PubMed ID: 1433799
    [No Abstract]   [Full Text] [Related]  

  • 2. Mega doses of methotrexate in the treatment of osteosarcoma.
    Iqbal MP; Malik IA
    J Pak Med Assoc; 1990 Oct; 40(10):248-51. PubMed ID: 2123265
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of medium- and high-dose methotrexate in the management of malignant childhood diseases].
    Nagy K; Hunyadi K; Velkey L
    Orv Hetil; 1983 Jun; 124(24):1433-9. PubMed ID: 6576318
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
    Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of non-renal elimination mechanisms of methotrexate (MTX)].
    Erttmann R; Gkanatsas A
    Monatsschr Kinderheilkd; 1985 Aug; 133(8):516-9. PubMed ID: 3876505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
    Johansson ÅM; Hill N; Perisoglou M; Whelan J; Karlsson MO; Standing JF
    Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-induced bullous acral erythema in a child.
    Werchniak AE; Chaffee S; Dinulos JG
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S93-5. PubMed ID: 15858519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
    Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma.
    Delepine N; Delepine G; Cornille H; Brion F; Arnaud P; Desbois JC
    Anticancer Res; 1995; 15(2):489-94. PubMed ID: 7763028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic individualization of high-dose methotrexate chemotherapy for the treatment of localized osteosarcoma.
    Fujita Y; Nakamura T; Aomori T; Nishiba H; Shinozaki H; Yanagawa T; Takagishi K; Watanabe H; Okada Y; Nakamura K; Horiuchi R; Yamamoto K
    J Chemother; 2010 Jun; 22(3):186-90. PubMed ID: 20566424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient case involving high-dose methotrexate followed by leucovorin rescue.
    Alsop JA
    Am J Hosp Pharm; 1978 Feb; 35(2):127. PubMed ID: 305201
    [No Abstract]   [Full Text] [Related]  

  • 12. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis.
    Stewart CF; Fleming RA; Arkin CR; Evans WE
    Clin Pharmacol Ther; 1990 Apr; 47(4):540-6. PubMed ID: 2328562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of chemotherapy of osteosarcoma].
    Zborzil J; Jasińska-Rubach M
    Nowotwory; 1979; Suppl():145-9. PubMed ID: 396518
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose methotrexate in fibroblastic osteosarcoma.
    Chowbay B; Siong KK
    Ann Pharmacother; 2001 Dec; 35(12):1669. PubMed ID: 11793640
    [No Abstract]   [Full Text] [Related]  

  • 15. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.
    Allen JC; Rosen G
    Ann Neurol; 1978 May; 3(5):441-4. PubMed ID: 310278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance.
    Jaffe N; Gorlick R
    J Clin Oncol; 2008 Sep; 26(27):4365-6. PubMed ID: 18802144
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteosarcoma of the leg; treatment results following preoperative chemotherapy].
    Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Goëken LN; Oosterhuis JW; Akkerboom JC
    Ned Tijdschr Geneeskd; 1986 Mar; 130(12):545-8. PubMed ID: 3485773
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of omeprazole on the plasma clearance of methotrexate.
    Reid T; Yuen A; Catolico M; Carlson RW
    Cancer Chemother Pharmacol; 1993; 33(1):82-4. PubMed ID: 8269594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femur replacement.
    Staudt AR
    Am J Nurs; 1975 Aug; 75(8):1346-8. PubMed ID: 1080013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
    Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
    Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.